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doi:10.1016/j.pedneo.2012.01.012Background: Maternalefetal ABO incompatibility is one of the causes of neonatal hyperbiliru-
binemia. We postulate that hemoglobin (Hb), hematocrit (Hct), and red blood cell (RBC) values
for cord blood units (CBUs) are lower and erythroblast values higher for maternalefetal ABO
incompatible dyads than for compatible dyads.
Objective: We investigated the relationship between Hb, Hct, RBC, and erythroblast CBU
values and maternalefetal ABO blood type compatibility.
Methods: Mothers having blood group O who gave birth to infants with blood group A, B, or AB
were classified as Group I. According to baby’s blood group, the members of Group I were
further divided into AO (baby group A, mother group O), BO (baby group B, mother group
O), and ABO (baby group AB, mother group O) subgroups. Mothers having blood group A who
gave birth to infants with blood group B or AB and mothers having blood group B who gave birth
to infants with blood group A or AB were classified as Group II. All other maternalefetal blood
type pairs were considered ABO compatible and were classified as Group III. We compared
mean Hb, Hct, RBC, and erythroblast values for the infants’ CBUs among these three groups
including the subgroups of Group I.
Results: Group I had lower mean Hb, Hct, and RBC values than Group II and Group III (both
p < 0.001). Although the mean Hb, Hct, and RBC values for Group II were lower than forof Hematology and Oncology, Buddhist Tzu-Chi General Hospital, Hualien, 707, Sec. 3, Chung-Yang
m.tw (T.-F. Wang).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
Cord blood unit RBC index and ABO incompatibility 139Group III, the difference was not statistically significant. Mean Hb and RBC for the AO group
were higher and nucleated RBC (nRBC) ratios were lower than for the BO group; however,
these differences were also not statistically significant. Interestingly, the mean Hct value of
the BO group was significantly lower than that of the AO group (p Z 0.04).
Conclusion: Group A or B neonates with a group O mother have lower mean Hb, Hct, and RBC
values for CBUs than other neonates. The role of RBC indices in predicting neonatal hemolytic
hyperbilirubinemia remains unclear and further studies are needed to identify the possible
clinical association.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Hemolytic disease of the newborns (HDN) due to maternal
antibodies is a situation in which the lifespan of the
neonate’s red cells is shortened due to the activity of
transplacental maternal antibodies. More than 99.5% of
Taiwanese are D Rh positive and, therefore, HDN due to
anti-D antibodies is rarely encountered.1 In addition,
hemolytic disease resulting from ABO incompatibility is
clinically milder than anti-D disease. However, HDN and
kernicterus do occasionally occur, and hydrops fetalis has
been suggested as a result.2,3 Thus, it is desirable to have
a simple and reliable test that is able to predict the
development of neonatal hyperbilirubinemia due to ABO
incompatibility, after which preventive phototherapy can
be used. Hemoglobin (Hb) levels, hematocrit (Hct) counts,
reticulocyte counts, direct Coombs test results, bilirubin
levels, and immunoglobulin G (IgG) titers that have been
obtained from cord blood together with maternal anti-A/
anti-B titers have been suggested as approaches for pre-
dicting the severity of hyperbilirubinemia in ABO HDN.4e10
A complete blood count (CBC) test is an absolute
requirement before any CBU cryopreservation. CBC testing
of CBUs is noninvasive, convenient, simple, and rapid. We
hypothesized that ABO incompatibility influences Hb, Hct,
red blood cell (RBC), and erythroblast values obtained from
CBU. The veracity of this hypothesis could be tested using
reference data and then used to help predict ABO incom-
patibility that is related to HDN. Most studies reported in
the literature, when obtaining CBC samples, have used cord
blood obtained directly from the umbilical veins at delivery
rather than cord blood units. To our best knowledge, no
similar study has been reported to date involving a sample
of this great size. Using 3688 CBUs, we studied the impact
of differences in the mothers’ and fetuses’ blood type
combinations on Hb, Hct, RBC, and erythroblast values for
CBUs.
2. Materials and Methods
2.1. Cord blood collection
Between September 2001 and November 2006, donated
cord blood samples from healthy Taiwanese singleton
neonates with a gestational age more than 36 weeks born to
married mothers were collected by the Tzu Chi Cord BloodBank. CBUs with a net weight of more than 90 g were
accepted. CBUs where one parent carried thalassemia were
not accepted, and collected CBUs were discarded if the
baby was diagnosed as having glucose-6-phosphate dehy-
drogenase deficiency (G-6-PD) deficiency. Written informed
consent was obtained from the mother donating the CBU
before collection. All CBUs were collected in utero using
a standard procedure. After delivery, the cord was steril-
ized and a 16-gauze needle was inserted into the umbilical
vein. The cord blood was collected by gravity into a col-
lecting bag containing 28 mL anticoagulant phosphate-
citrate-dextrose. The bag was stored at 4C to 10C and
sent to Tzu Chi Cord Blood Bank within 24 hours. Between
1 mL and 2 mL of the aspirated cord blood from cord blood
bag was infused into an EDTA tube. Subsequently, the cord
blood CBC, white blood cell differential count (WBC DC), Rh
typing, and ABO typing were analyzed in the central labo-
ratory of Hualien Buddhist Tzu Chi General Hospital by
experienced technicians. Blood group typing was per-
formed routinely using standard blood bank techniques.
2.2. Analysis of cord blood CBC and WBC DC
The CBC testing included RBC, Hb, Hct, WBC, and platelet
counts, which were measured using a Sysmex XE2100
automated hematology analyzer (Sysmex Corporation,
Kobe, Japan). Nucleated RBCs (nRBCs) were reported as the
number of nucleated RBCs per 100 WBCs. According to
the quality control chart and Westgard rules 13S/22S/R4S,
the analyzer was calibrated twice daily using a commercial
assayed control cell.11
2.3. Materials
Among the 5602 CBUs available, 1913 units lacked some
data, and these were excluded. Furthermore, there was
only one unit where the mother was AB blood group and
baby was O group, therefore we excluded this CBU also. In
total, 3688 healthy neonates were included in this study,
and these were divided into three groups. Mothers having
blood group O who had given birth to infants having blood
group A, B, or AB were classified as Group I. Group I con-
sisted of 555 CBUs (A, B, and AB; 305, 247, and 3, respec-
tively) where the newborn’s mother’s blood group was O.
Mothers having blood group A who had given birth to infants
having blood group B or AB together with mothers having
blood group B who gave birth to infants having blood group
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140 S.-H. Chen et alA or AB were classified as Group II. Group II consisted of 326
newborns. Groups I and II were both considered to be
maternalefetal ABO-incompatible pairs. All other mater-
nalefetal blood group pairs were considered ABO-
compatible and were classified as Group III. Group III
consisted of 2807 newborns. According to the baby’s blood
group, either A, B, or AB, Group I was further divided to AO
(mother O group with baby A), BO (mother O group with
baby B), and ABO (mother O group with baby AB) subgroups
and there were 305, 247, and 3 in the AO, BO, and AB
subgroups, respectively. Maternal, neonatal, and cord
blood data was then obtained from medical records for
each CBU sample.
2.4. Statistical analysis
The gender of neonate and delivery route for the studied
groups were compared by Chi-square test. The significance
of differences for the CBU mean values for Hb, Hct, nRBC
ratios, and RBC together with maternal age, gestational
age, neonate’s birth body weight, and cord blood weight
across the three groups were evaluated by ANOVA. We used
Student t test to evaluate the differences in mean Hb, Hct,
nRBC ratios, and RBC across the AO and BO subgroups of
Group I. A p value <0.05 was considered to be statistically
significant.
3. Results
Totally, 3688 units of cord blood were eligible for analysis,
and none of the mothers/infants were found to be DRh-
positive blood type. There were 555, 326, and 2807 infants
in Groups I, II, and III, respectively. In Group I, there were
305 infants in the AO subgroup and 247 infants in the BO
subgroup. The mean, median, minimum, and maximum
values for Hb, Hct, nRBC ratio, RBC, maternal age, gesta-
tional age, baby’s birth body weight, and cord blood weight
across the three groups are listed in Table 1. This shows
that there was no statistical difference for gender (male/
female ratio) or delivery route (vaginal delivery vs.
cesarean section) across the groups. However, the means
for Hb, Hct, and RBC values for Group I were significantly
lower than those for Groups II and III (Hb: 10.6 g/dL, 10.8 g/
dL, and 10.9 g/dL, respectively, p < 0.001; Ht: 35.1%,
35.7%, and 36.2%, p < 0.001; RBC: 3.01,  106/mL,
3.11  106/mL, and 3.14106/mL, p < 0.001). Although the
mean Hb, Hct, and RBC values for Group II were lower than
for Group III, these differences were not statistically
significant. Furthermore, no significant differences were
found among Groups I, II, and III when their nRBC ratios,
maternal age, gestational age, infant’s birth body weight,
and cord blood weight were analyzed. These findings are
presented in Table 2. In Group I, the mean Hct value of the
BO subgroup was significantly lower than that of the AO
group (34.7% for the BO group vs. 35.4% for the AO group,
p Z 0.04) (Table 3). Although there were no statistical
differences in mean Hb, nRBC ratios, and RBC between the
AO and BO subgroups, the mean Hb and RBC values for the
AO group were higher and the nRBC ratios lower than for
the BO group (Hb Z 10.7 g/dL, 10.4 g/dL, respectively,
pZ 0.06; RBC Z 3.04106/mL, 2.98106/mL, respectively,
Table 2 Comparison of the mean Hb, Hct, RBC, nRBC ratio, maternal age, gestational age, cord blood volume, and cord blood
weight across Groups I, II, and III.
Group I (N Z 555) Group II (N Z 326) Group III (N Z 2807) p value
Gender, M/F (%)* 289/266 (52.1/47.9) 146/180 (44.8/55.2) 1475/1332 (52.5/47.5) 0.38
Vaginal/CS (%)* 411/144 (74.1/25.9) 247/79 (75.8/24.2) 2029/778 (72.3/27.7) 0.25
RBC (106/mL) 3.01 3.11 3.14 <0.001
Hb (g/dL) 10.6 10.8 10.9 <0.001
Hct (%) 35.1 35.7 36.2 <0.001
nRBC (/100 WBCs) 3.80 3.25 3.19 0.07
Age of mother (y) 29.9 29.8 29.8 0.92
Gestational age (weeks) 38.8 38.9 38.9 0.54
Weight of cord blood unit (g) 141.2 141.7 141 0.84
Baby birth body weight (g) 3257.5 3248.1 3251.8 0.92
Data are presented as the means and are compared by ANOVA test.
N Z sample size; M Z male; F Z female; CS Z cesarean section; Hb Z hemoglobin; Hct Z hematocrit; nRBC Z nucleated red blood
cells; WBC Z white blood cells.
* Chi-square test.
Cord blood unit RBC index and ABO incompatibility 141p Z 0.10; nRBC Z 3.78, 3.84, respectively, p Z 0.93)
(Table 3).
4. Discussion
Many etiological factors are involved in the development
of neonatal hyperbilirubinemia. For example, UDP-
glucuronosyl transferase 1A1 (UGT1A1) is the key enzyme
in bilirubin conjugation, and Huang et al’s study on varia-
tion at nucleotide 211 of the UGT1A1 gene shows that this is
a risk factor for the development of neonatal hyper-
bilirubinemia among Taiwanese. The variant rate within the
coding region of the UGT1A1 gene in Taiwanese was found
to be 29.3%.12 In addition, ABO incompatibility is consid-
ered to be one of the most common causes of neonatal
hyperbilirubinemia. The major anti-A and anti-B antibodies
in blood group B and A individuals are immunoglobulin M
(IgM); however, these antibodies in group O individuals are
usually mostly IgG. The only immunoglobulin transferred
from mother to fetus via the placenta is IgG. Lin et al
reported that mothers and infants had the same anti-A and
anti-B IgG titers when group O mothers and infants were
compared.13 ABO HDN is considered to occur relatively
frequently and can be a significant cause of neonatal
morbidity. In 14.3% of all pregnancies in Taiwanese, theTable 3 Comparison of the mean Hb, Hct, nRBC ratio, and
RBC between the AO and BO subgroups within Group I.
AO subgroup
(N Z 305)
BO subgroup
(N Z 247)
p value
RBC (106/mL) 3.04 2.98 0.10
Hb (g/dL) 10.7 10.4 0.06
Hct (%) 35.4 34.7 0.04
nRBC (/100 WBCs) 3.78 3.84 0.93
Data are presented as means and compared by Student t test.
Hb Z hemoglobin; Hct Z hematocrit; N Z sample size;
nRBC Z nucleated red blood cells; WBC Z white blood cells.mother is O and her neonate is either A or B.14 However,
ABO incompatibility-induced clinically severe hemolytic
disease is comparatively rare. There are three main reasons
for this. First, A and B blood type antigens are expressed at
a low level on fetal RBCs. Second, IgG ABO antibodies are
usually IgG2, which does not initiate RBC destruction.
Thirdly, ABO antigens are present in many tissues, and any
IgG antibodies crossing the placenta are likely to become
bound to placental tissue.15e18 As a result, this disease is
usually mild; nevertheless, severe hemolysis may occa-
sionally occur. Taiwanese neonatal jaundice has been found
to be more severe than that found in Black and Caucasian
populations.9 Desjardins et al reported that among 1704
infants of blood group O mothers, infants with blood groups
A or B had significantly lower cord blood Hb concentrations
than did newborns with blood group O; they concluded that
most ABO-incompatible infants showed some degree of
hemolytic disease even though antibodies were not
demonstrated by either the Coombs or eluate test.19 In our
study, Group I infants have a lower mean Hb, Hct, and RBC
than the other two groups, and this supports Desjardins
et al’s findings. Chen and Ling demonstrated that a high IgG
titer among group O mothers was associated with the
development of ABO HDN in Taiwan.10 However, in Taiwan,
the cause of neonatal hyperbilirubinemia is quite compli-
cated because close to 30% of the population have the
UGT1A1 gene mutation associated with hyperbilirubinemia.
In group A and B individuals, naturally occurring anti-B
and anti-A antibodies are mainly IgM, which cannot cross
the placenta. By contrast, in the group O individuals, anti-A
and anti-B antibodies are predominantly IgG, which can
cross the placenta. Dufour and Monoghan reported that
37.9% of group O mothers having blood group A or B infants
showed laboratory evidence of ABO HDN, whereas only 0.8%
of mothers of group A with infants having blood group B or
AB and mothers of group B with infants having blood group
A or AB showed laboratory evidence of HDN.20 In our study,
the values for Hb, Hct, and RBC in Group I were significantly
lower than those for Groups II and III (Hb: 10.6 g/dL, 10.8 g/
dL, and 10.9 g/dL, respectively, p < 0.001; Ht: 35.1%,
142 S.-H. Chen et al35.7%, and 36.2%, p < 0.001; RBC: 3.01  106/mL,
3.11  106/mL and 3.14  106/mL, p < 0.001). Furthermore,
Group II had lower Hb, Hct, and RBC values than Group III
(Hb 10.8 g/dL, 10.9 g/dL, respectively; Hct 35.7%, 36.2;
RBC 3.11  106/mL, 3.14  106/mL), but these differences
did not reach statistical significance. Thus, our results were
consistent with Dufour and Monoghan’s findings.
nRBCs are immature RBCs. Many pathological conditions,
including hemolytic disease and bleeding, can cause an
increase in the number of nRBCs. Hanlon-Lundberg and Kirby
evaluated 1661 neonates and reported that cord blood nRBC
counts were lower in infants with ABO compatibility than in
infants with ABO incompatibility and that group B infants
who were borne by group O mothers had the highest nRBC
counts.21 However, the differences in nRBC ratios in our
three groups did not reach statistical significance; further-
more, there was also no significant difference between the
AO and BO subgroups for the nRBC ratios. Their study
obtained the CBC samples directly from the umbilical vein.
Our study obtained the CBC samples from a cord blood bag
that contained 28 mL of anticoagulant, and this might have
caused a dilution effect. This difference in CBC sample
collection may explain the different results.
HDN in Group B infants due to blood group antibodies
was claimed to be more severe than HDN hemolytic
disease in Group A infants in some studies.4,22,23 However,
some other studies have reported no difference in
severity between AO and BO incompatibility.9,11 In our
study, mean Hb and RBC were 10.7 g/dL, 3.04  106/mL,
and 10.4 g/dL, 2.98  106/mL in AO and BO group,
respectively. Although the mean Hb and RBC values for
the BO group were lower than those for the AO group, the
difference did not reach statistical significance. Further-
more, although the nRBC ratio in the BO group was higher
than in AO group, again, the difference was not statisti-
cally significant (3.78 and 3.84 in AO and BO groups,
respectively). Interestingly, the Hct for the AO group was
higher than for the BO group (35.4% and 34.7% in AO and
BO subgroups, respectively) and this difference was
statistically significant (p Z 0.04).
CBU Hb, Hct, and RBC values are part of the routine
data collected by all cord blood banks. We have estab-
lished Taiwanese cord blood CBC normal reference values
and the mean values for Hb, Hct, RBC, and nRBC are
11.2 g/dL, 36.9 (%), 3.22  106/mL, and 3.4/100 WBC),
respectively.24 We can probably use these RBC indices as
a reference for predicting ABO HDN. In this study, there
was no personal identification data available because of
confidentiality regulations of the public cord blood bank,
and therefore, a clinical analysis of the incidence of
hyperbilirubinemia was impossible. Nonetheless, it seems
likely that CBU Hb, Hct, reticulocyte count, direct Coombs
test, eluate test, and bilirubin result may help with pre-
dicting the severity of hyperbilirubinemia in ABO
HDN.4e10,13,25 However, these laboratory results do not
provide a reliable early diagnosis for ABO HDN because
neonatal hyperbilirubinemia involves multiple etiologies.
These etiologies include UGT1A1 gene variations, maturity
of the neonatal liver, conditions that increase bilirubin
production, conditions that increase enterohepatic circu-
lation and breast feeding failure. Further study needs to
focus on the association between CBU laboratory valuesand clinical outcome in order to clarify the clinical role of
the CBU RBC indices.
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